Effect of hypothyroidism on the NO/cGMP pathway of corpus cavernosum in rabbits

Journal of Sexual Medicine

Volumn 3, Issue 5, 2006, Pages 830-837

  Kilicarslan, Hakan ^a   Bagcivan, Ihsan ^b   Yildirim, M Kemal ^b   Sarac, Bulent ^b   Kaya, Tijen ^b  

^a ULUDAG UNIVERSITY   (Turkey)

^b CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Animal models; Endocrinologic studies of sexual function; Pharmacologic studies in sexual function

Indexed keywords

CALCIUM; CARBACHOL; CYCLIC GMP; LIOTHYRONINE; NITRIC OXIDE; PAPAVERINE; PARATHYROID HORMONE; PROLACTIN; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALCIUM BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ELECTRIC FIELD; ENDOTHELIUM; HYPOTHYROIDISM; IMPOTENCE; MALE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RABBIT; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

EID: 33747747604     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00289.x     Document Type: Article

References (37)

1. Saenz de Tejada I, Blanco R, Goldstein I. Cholinergic neurotransmission in human corpus cavernosum. Responses of isolated tissue. Am J Physiol 1988; 254: 459-67.
2. Andersson KE, Holmquist F. Mechanisms for contraction and relaxation of human penile smooth muscle. Int J Impot Res 1990; 2: 209-25.
3. Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Snyder SH. Nitric oxide-A physiologic mediator of penile erection. Science 1992; 257: 401-3.
4. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol 1987; 137: 829-36.
5. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191-236.
6. Saenz de Tejada I, Angulo J, Cellek S, Gonzalez-Cadavid N, Heaton J, Pickard R, Simonsen U. Physiology of erectile function. J Sex Med 2004; 1: 254-65.
7. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90-2.
8. Bagcivan I, Kilicarslan H, Sarac B, Gokce G, Yildirim S, Ayan S, Sarioglu Y. The evaluation of the effects of renal failure on erectile dysfunction in a rabbit model of chronic renal failure. BJU Int 2003; 91: 697-701.
9. Christ GJ. The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection. Urol Clin North Am 1995; 22: 727-45.
10. Trigo-Rocha F, Hsu GL, Donatucci CF, Lue TF. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection. J Urol 1993; 149: 872-7.
11. Azadzoi KM, Kim N, Brown ML, Goldstein I, Cohen RA, Saenz de Tejada I. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol 1992; 147: 220-5.
12. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 170: 843-50.
13. Walsh PC, Wilson JD. Impotence and infertility in men. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al., eds. Harrison's principles of internal medicine, 11th edn. New York: McGraw-Hill; 1987: 219.
14. Plum F. Autonomic disorders and their management. In: Wyngaarden JB, Smith LH, eds. Cecil's textbook of medicine. 17th edn. Philadelphia, PA: W.B. Saunders; 1985: 2030.
15. Spark RF, White RA, Connolly PB. Impotence is not always psychogenic. JAMA 1980; 243: 750-5.
16. Slag MF, Morley JE, Elson MK. Impotence in medical clinic outpatients. JAMA 1983; 249: 1736-40.
17. Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, Tan HM, Torres LO. Endocrine aspects of sexual dysfunction in men. J Sex Med 2004; 1: 69-81.
18. Baskin HJ. Endocrinologic evaluation of impotence. South Med J 1989; 82: 446-9.
19. De La Balze FA, Arrillaga F, Mancini RE, Janches M, Davidson OW, Gurtman AL. Male hypogonadism in hypothyroidism: A study of six cases. J Clin Endocrinol Metab 1962; 22: 212-22.
20. Hembree WC. Male reproductive system. In: Werner SC, Ingbar SH, eds. The thyroid. Hagerstown, MD: Harper & Row; 1978: 919-22.
21. Qiu Y, Kraft P, Lombardi E, Clancy J. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum. J Urol 2000; 164: 882-6.
22. Mulsch A, Bauersachs J, Schafer A, Stasch JP, Kast R, Busse R. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol 1997; 120: 681-9.
23. Friebe A, Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol 1998; 53: 123-7.
24. Lee YC, Martin E, Murad F. Human recombinant soluble guanylyl cyclase: Expression, purification, regulation. Proc Natl Acad Sci USA 2000; 97: 10763-8.
25. Nakane M, Hsieh GC, Miller LN, Chang R, Terranova MA, Moreland RB, Kolasa T, Brioni JD. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: Synergism of nitric oxide and YC-1. Int J Impot Res 2002; 14: 121-7.
26. Schmidt K, Schrammel A, Koesling D, Mayer B. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells. Mol Pharmacol 2001; 59: 220-4.
27. Stone JR, Marletta MA. Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: Implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem Biol 1998; 5: 255-61.
28. Morley D, Keefer LK. Nitric oxide/nucleophile complexes: A unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 1993; 22: 3-9.
29. Cetin A, Kaya T, Demirkoprulu N, Karadas B, Duran B, Cetin M. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium. J Pharmacol Sci 2004; 94: 19-24.
30. Hsieh GC, O'Neill AB, Moreland RB, Sullivan JP, Brioni JD. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats. Eur J Pharmacol 2003; 458: 183-9.
31. Salom JB, Barbera MD, Centeno JM, Orti M, Torregrosa G, Alborch E. Comparative relaxant effects of the NO donors sodium nitroprusside, DEA/ NO and SPER/NO in rabbit carotid arteries. Gen Pharmacol 1999; 32: 75-9.
32. Taher A, Meyer M, Stief CG, Jonas U, Forssmann WG. Cyclic nucleotid phosphodiesterase in human corpus cavernous smooth muscle. World J Urol 1997; 15: 32-5.
33. Stief CG, Uckert S, Becker AJ, Truss MJ, Jonas U. The effect of the specific phosphodiesterase inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol 1998; 159: 1390-3.
34. Ballard SA, Gingell CJ, Tank G, Turner LA, Price ME, Naylor AM. Effects on sildenafil the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 159: 2164-71.
35. Holl JE, Howard LS. Suitability of the rabbit for hypothyroidy studies. Res Commun Chem Pathol Pharmacol 1997; 1: 185-8.
36. Ayan S, Yildirim S, Ucar C, Sariog̀lu Y, Gultekin Y, Butuner C. Corporal reactivity to adenosine and prostaglandin E 1 in alloxan-induced diabetic rabbit corpus cavernosum, and the effect of insulin therapy. BJU Int 1999; 83: 108-12.
37. Alm P, Larsson B, Ekblad E, Sundler F, Andersson KE. Immunohistochemical localization of peripheral nitric oxide synthase containing nerve using antibodies raised agonist synthesised C and N-terminal fragments of cloned enzyme from rat brain. Acta Physiol Scand 1993; 148: 421-9.